VELAN CAPITAL, L.P. purchased 2.8% of their position (204.06K shares) of PROGENICS PHARMACEUTICALS INC on the open market
Open‑market purchase worth $878.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/27/2019ACC: 0000921895-19-002346
10% OwnerOther
Since Aug 2019
+204.06K
Net shares
Net buyer
$878.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
204.06K acquired
Non-Derivative Transactions2
Common Stock, $0.0013 par value
Direct
Shares
+130.83K
Price / share
$4.31
Trade value
$563.69K
% of position
1.8%
8/23/2019
7.21M→7.35M
Common Stock, $0.0013 par value
Direct
Shares
+73.23K
Price / share
$4.30
Trade value
$314.91K
% of position
1.0%
8/26/2019
7.35M→7.42M
Total
Net shares
+204.06K
Net value
$878.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0013 par value Direct | 8/23/2019 | P · Purchase | +130.83K | $4.31 | $563.69K | 1.8% | 7.21M | 7.35M |
| Common Stock, $0.0013 par value Direct | 8/26/2019 | P · Purchase | +73.23K | $4.30 | $314.91K | 1.0% | 7.35M | 7.42M |
| Total | +204.06K | $878.60K | ||||||
Derivative Transactions0
No derivative transactions reported